Lawton Alison Frances 4
4 · Kaleido Biosciences, Inc. · Filed Nov 18, 2019
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
DirectorSee Remarks
Transactions
- Award
Stock Option (Right to Buy)
2019-11-15−150,000→ 150,000 totalExercise: $6.56Exp: 2029-11-14→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on November 15, 2020, with the remaining 75% vesting in equal quarterly installments over the next three years.